# In Market Utilisation of Liraglutide Used for Weight Management in the UK: a Study in the CPRD Primary Care Database

> **NCT03479762** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 105 (actual)

## Conditions studied

- Obesity
- Overweight

## Interventions

- **DRUG:** Liraglutide

## Key facts

- **NCT ID:** NCT03479762
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-20
- **Primary completion:** 2022-09-12
- **Final completion:** 2022-09-12
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2022-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03479762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03479762, "In Market Utilisation of Liraglutide Used for Weight Management in the UK: a Study in the CPRD Primary Care Database". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03479762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*